期刊文献+

代谢综合征患者血清高敏C-反应蛋白的变化及临床意义 被引量:1

The level of serum high sensitive C-reactive protein in the patients with metabolic syndrome and it's clinical value
在线阅读 下载PDF
导出
摘要 目的 观察代谢综合征患者血清高敏C-反应蛋白(hs-CRP)水平的变化,以评价hs-CRP与代谢综合征的临床相关性及意义.方法 用免疫比浊法测定加例代谢综合征患者和30例健康对照者的血清hs-CRP水平,并两两比较.观察hs-CRP与腰围、血压、空腹血糖(FBG)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)及高密度脂蛋白胆固醇(HDL-C)的相关性.结果与健康对照组比较,代谢综合征患者的hs-CRP水平显著升高(P=0.006),且hs-CRP水平与腰围、收缩压、舒张压、TG、TC、LDL-C、FBG成正相关(r分别为0.37、0.28、0.26、0.39、0.21、0.23、0.18,P<0.05),与HDL-C成负相关(r=-0.31,p=0.004).结论 hs-CRP可作为临床诊断代谢综合征及评价代谢综合征患者心血管疾病危险性增加的一个简易指标.
机构地区 [
出处 《中国心血管病研究》 CAS 2009年第7期488-490,共3页 Chinese Journal of Cardiovascular Research
  • 相关文献

参考文献7

  • 1[1]Reaven GM.Role of insulin resistance in human disease.Diabetes,1988,37:1595-1607.
  • 2宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:615
  • 3[6]Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus.JAMA,2001,286:327-334.
  • 4[7]Dandona P,Mohanty P,Hamouda W,et al.Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyresine concentrations.J Clin Endocrinol Metab,2001,86:2899-2902.
  • 5[8]Kern PA,Ranganathan S,Li C,et al.Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.Am J Physiol Endocrinol Metab,2001,280:E745-751.
  • 6[9]Hotamisligil GS,Peraldi P,Budavari A,et al.IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance.Science,1996,271:665-668.
  • 7[10]Dandona P,Aljada A,Mohanty P.The anti-inflammatory and potential anti-atherogenic effect of insulin:a new paradigm.Diabetologia,2002,45:924-930.

二级参考文献22

  • 1Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 2Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 3Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 4Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 5Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 6Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 7Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 8Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 9Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.
  • 10Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet,2003,361:2005-2016.

共引文献614

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部